West China Second University Hospital

This study tests whether adding a targeted drug called luvometinib to standard chemotherapy works better than chemotherapy alone for children with severe multisystem Langerhans cell histiocytosis (LCH). LCH is a rare immune cell disorder that can damage multiple organs and often …